Abstract-Intravenous infusion of platelet activating factor (PAF) causes an ac cumulation of platelets within the thorax of the guinea pig that is accompanied by
buffer by cardiac puncture from an ether anesthetized guinea pig (4) and placed in polystyrene tubes. After centrifugation (200xg for 10 min), platelet-rich plasma (PRP) was removed and mixed with an equal volume of citrate buffer. Following a second centrifuga tion (1000xgfor10min), the supernatant was discarded and platelets were resuspended in 1 ml of citrate buffer. Platelet numbers were determined using an automated platelet counter (Cell-dyn 100, Sequoia-Turner, U.S.A.). After addition of "'Indium oxine (1.5 MBq), the platelet suspension was in cubated for 5 min at room temperature and then centrifuged (1000xg for 10 min). Unbound "'Indium oxine in the supernatant was discarded, and the surface of the platelet pellet was washed twice with citrate buffer to remove unbound "'Indium associated with the meniscus. Platelets were resuspended (5.0-9.0 x 108/ml) in 1 ml of citrate buffer, and 0.3 ml aliquots of the platelet suspension were injected intravenously via a jugular vein or a dorsal foot vein into recipient guinea pigs; 1 ml of heparinized saline was injected to maintain patency of the cannula. "'Indium-labeled platelets that were in jected into recipient animals comprised be tween 2 and 8% of the circulating platelet population (5).
Monitoring of 1 t t Indium-labeled platelets: Anesthetized, spontaneously breathing guinea pigs (groups of 3 to 4) were placed supine, and a collimated sodium iodide crystal scintillation detector (1 inch crystal, DM1 -1, Nuclear Enterprises, England) was placed above the thorax and abdomen of each animal. NIMS series amplifier/analyzers (Nuclear Enterprise 4697) were used to amplify and select signals from each detector. Pulses from the NE 4697 modules were log ged at up to 5 MHz by an eight channel co processor (AIMSplus, Mumed Ltd., England) within a host computer (IBM AT3), and count rates (cpm) were displayed graphically in real time as an index of intrathoracic platelet content (5) .
Immediately following injection of platelets, count rates over the thorax were stable (circa 10,000/sec) ; nevertheless, a period of 5-10 min was allowed to elapse before com mencing an experiment. PAF (600 ng/kg/hr) was infused in a graded fashion over a one hour period (30 ng/kg for 10 min, followed by 120 ng/kg for 20 min, followed by 450 ng/ kg for 30 min) so that the bulk of the PAF was given in the final 30 min. Recording com menced 4 min before infusion of PAF, and count rates were recorded over 90 successive 60-sec periods.
Drug administration: When testing for inhibition of platelet accumulation, drugs or putative inhibitors were injected intravenously as a bolus 1 min prior to the infusion of PAF and concommitantly with the PAF infusion; i.e., ketotifen
(1:1 mg/kg) indicates that ketotifen was injected as a bolus (1 mg/kg) 1 min prior to infusion of PAF and as an in fusion (1 mg/kg) together with the PAF infusion.
Results
Anti-asthma drugs and platelet accumu lation: Intravenous infusion of PAF (300 ng/ kg/hr) did not cause noteworthy intrathoracic accumulation of "'Indium-labeled platelets (maximal increase above pretreatment count rates was 1.6±3%; n=5). Intravenous in fusion of PAF (600 ng/kg/hr) caused an intrathoracic accumulation of "'Indium labeled platelets (maximal increase above pretreatment count rates was 50±9%, n=6) that was associated with development of airway hyperreactivity (Fig. 1) . Ketotifen (1 :1 mg/kg), cromoglycate (10:10 mg/kg), aninophylline (10:10mg/kg) and prednisolone (10:10 mg/kg) did not diminish intrathoracic platelet accumulation (Fig. 2) , even though at these doses, development of airway hy perreactivity was effectively inhibited (pre ceding paper). The inability of these drugs to inhibit platelet accumulation due to PAF can be contrasted with the capacity of these drugs to inhibit airway hyperreactivity (Table  1 ) .
PAF antagonists and platelet accumulation: Two competitive inhibitors of PAF receptor binding sites on isolated platelets (SRI 63 441 and Gingkolide B) (6) were used in this study. Both Gingkolide B (1:1 mg/kg) and SRI 63-441 (1:1 mg/kg) strongly inhibited intrathoracic platelet accumulation due to infusion of PAF as illustrated in Fig. 3 . At this dosage, both compounds fully inhibited the induction of airway hyperreactivity by such an infusion of PAF (Table 1) . Discussion PAF may evoke pronounced biological effects as consequences of platelet activa tion or by mechanisms that are independent of platelet activation (6) . For instance, the increased airway resistance and decreased dynamic compliance that follow intravenous injection of PAF are no longer detectable in animals depleted of platelets (7, 8) . By way of contrast, increased vascular permeability in guinea pig skin is not influenced by depletion of platelets (9) . Development of airway hyperreactivity in guinea pigs is a platelet-dependent pheno menon, for there is no change in airway re activity when animals that have been depleted of platelets are exposed to PAF (2). Ac Each group is comprised of 6 animals and bars depict S.E.M. (8, 10, 11) . Nonetheless, it has been proposed that platelet activation is necessary in order that eosinophils might ac cumulate within the airway of laboratory animals during responses to either PAF or allergen (12, 13 (16) is not at variance with the con cept that PAF and platelet activation par ticipate in asthma. The present studies in the guinea pig are consistent with the dissocia tion of platelet aggregation from development of airway hyperreactivity, since prophylactic anti-asthma drugs inhibited the development of airway hyperreactivity following exposure to PAF without influencing platelet aggrega tion.
Recent evidence implies that the action of ketotifen and prednisolone to achieve inhibi tion of airway hyperreactivity may be at tributed to an inhibition of the effects upon the airways of a platelet derived hyperreac tivity factor (17) that is generated when platelets interact with PAF (18). These ob servations are consistent with the interpre tation that platelet aggregation within the airways is not a determinant of airway hy perreactivity.
